2015 ANNUAL DATA REPORT
V
2: E
-S
R
D
Figure 9.1 Causes of death in ESRD patients, 2013
Data Source: Reference Table H12. Abbreviations: AHD, atherosclerotic heart disease; AMI, acute myocardial infarction;
CHF, congestive heart failure; CVA, cerebrovascular accident.
Vol 2, ESRD, Ch 9 2
Figure 9.2 Prevalence of cardiovascular diseases in ESRD patients, by treatment modality, 2013
Data Source: Special analyses, USRDS ESRD Database. Point prevalent hemodialysis, peritoneal dialysis, and transplant patients at all ages, with Medicare as primary payer on January 1, 2011, who are continuously enrolled in Medicare Parts A and B from July, 1, 2010 to
December 31, 2010, ESRD service date is at least 90 days prior to January 1, 2011, and survived past 2012. Abbreviations: AFIB, atrial fibrillation; AMI, acute myocardial infarction; ASHD, atherosclerotic heart disease; CHF, congestive heart failure; CKD, chronic kidney disease; CVA/TIA, cerebrovascular accident/transient ischemic attack; CVD, cardiovascular disease; PAD, peripheral arterial disease;
SCA/VA, sudden cardiac arrest and ventricular arrhythmias.
Vol 2, ESRD, Ch 9 3
Figure 9.3 Prevalence of cardiovascular diseases in ESRD patients, by age, 2013
Data Source: Special analyses, USRDS ESRD Database. Point prevalent hemodialysis, peritoneal dialysis, and transplant patients at all ages, with Medicare as primary payer on January 1, 2011, who are continuously enrolled in Medicare Parts A and B from July, 1, 2010 to
December 31, 2010, ESRD service date is at least 90 days prior to January 1, 2011, and survived past 2012.Abbreviations: AFIB, atrial fibrillation; AMI, acute myocardial infarction; ASHD, atherosclerotic heart disease; CHF, congestive heart failure; CKD, chronic kidney disease; CVA/TIA, cerebrovascular accident/transient ischemic attack; CVD, cardiovascular disease; PAD, peripheral arterial disease;
SCA/VA, sudden cardiac arrest and ventricular arrhythmias.
Vol 2, ESRD, Ch 9 4
Table 9.1 Prevalence of cardiovascular diseases & procedures in ESRD patients, by treatment modality, age, race, & sex, 2013
% Patients
45-64 65-74 75+ White
Blk/Af
Am
Other Male Female
# Patients
Overall 0-21 22-44
Cardiovascular Comorbidities a
Atherosclerotic heart disease (ASHD)
Hemodialysis
Peritoneal dialysis
147,373
11,180
Transplant 23,465
Acute myocardial infarction (AMI)
40.8
32.0
22.3
2.5
0.9
0.4
Hemodialysis
Peritoneal dialysis
147,373
11,180
Transplant 23,465
Congestive heart failure (CHF)
13.7
11.2
7.3
0.0
0.5
0.0
Hemodialysis
Peritoneal dialysis
147,373
11,180
37.2
25.2
10.7
6.5
Transplant 23,465 18.7
2.2
Cerebrovascular accident/transient ischemic attack (CVA/TIA)
15.0
11.3
2.8
1.4
Hemodialysis
Peritoneal dialysis
147,373
11,180
Transplant 23,465
Peripheral artery disease (PAD)
Hemodialysis
Peritoneal dialysis
Transplant
Atrial fibrillation (AFIB)
147,373
11,180
23,465
Hemodialysis
Peritoneal dialysis
Transplant
147,373
11,180
23,465
7.8
30.0
20.7
13.9
19.5
14.1
12.4
0.6
10.3
5.6
0.7
0.7
0.0
0.0
15.6
11.9
6.1
5.4
4.1
2.3
22.4
16.0
6.9
16.3
10.7
5.0
5.0
3.8
1.8
5.5
5.5
2.4
36.8
31.7
19.3
12.5
11.1
6.8
33.7
23.8
15.5
12.5
9.9
6.2
28.5
20.7
12.7
14.5
10.4
8.3
49.7
44.0
36.8
16.5
15.6
11.2
42.2
32.0
29.1
19.0
16.6
13.0
34.6
27.7
21.3
23.3
21.0
22.4
52.1
49.1
43.2
17.4
17.2
13.5
45.9
35.5
39.5
20.3
17.4
17.5
34.9
26.8
25.0
32.0
32.1
34.7
45.1
35.4
24.0
15.1
12.6
7.9
37.8
25.5
19.1
15.0
12.0
8.2
31.2
22.3
14.6
23.2
16.4
13.9
36.0
25.7
19.0
12.1
9.0
6.1
37.1
25.6
18.8
15.4
10.7
7.5
29.3
18.4
13.0
15.3
9.8
9.3
38.4
27.5
18.3
12.1
8.1
6.1
32.0
21.3
13.8
13.0
7.6
5.2
23.9
15.2
10.2
17.2
11.2
9.7
40.9
36.5
24.0
13.7
12.8
7.8
35.4
27.2
18.9
13.5
11.0
7.6
29.9
22.3
15.0
19.7
16.8
13.6
40.7
27.5
19.7
13.6
9.6
6.5
39.4
23.3
18.4
16.9
11.6
8.1
30.0
19.0
12.3
19.2
11.5
10.5
Vol 2, ESRD, Ch 9 5
Table 9.1 Prevalence of cardiovascular diseases & procedures in ESRD patients,
by treatment modality, age, race, & sex, 2013 (Continued)
% Patients
# Patients
Overall 0-21 22-44 45-64 65-74 75+ White
Blk/Af
Am
Other Male Female
Cardiac arrest and ventricular arrhythmias (SCA/VA)
Hemodialysis
147,373
Peritoneal dialysis
11,180
Transplant
Cardiovascular Procedures b
23,465
7.3
6.0
4.0
0.4
2.3
0.2
3.8
3.2
1.0
Revascularization – percutaneous coronary interventions (PCI)
Hemodialysis 60,125
5.3
0.0
Peritoneal dialysis 3,578 6.2
0.0
Transplant 5,228 5.2
0.0
Revascularization – coronary artery bypass graft (CABG)
4.8
5.4
5.6
6.9
5.7
3.2
6.3
6.1
7.0
8.8
7.9
7.0
5.4
7.3
4.4
8.1
8.6
8.8
4.0
5.3
2.6
7.2
6.1
4.2
5.6
6.8
5.4
Hemodialysis 60,125
1.8
0.0
2.2
2.5
1.8
0.7
1.7
Peritoneal dialysis 3,578
2.6
0.0
2.9
2.8
2.8
2.0
2.7
Transplant 5,228
2.0
0.0
2.0
2.5
1.7
1.7
2.1
Implantable cardioverter defibrillators & cardiac resynchronization therapy with defibrillator (ICD/CRT-D)
54,775 0.8
0.0
0.9
0.9
0.9
0.5
0.8
Hemodialysis
Peritoneal dialysis
Transplant
2,818
4,384
1.0
1.0
0.0
0.0
0.3
0.0
1.0
1.3
1.1
1.0
1.2
0.7
0.9
1.1
7.5
6.3
3.8
4.7
5.3
4.5
1.7
2.5
1.5
0.7
1.2
0.7
6.0
3.6
3.5
6.3
3.1
5.5
2.4
2.2
3.1
0.8
0.6
0.5
7.5
6.7
4.5
5.4
6.0
5.4
2.0
3.4
2.0
1.0
1.1
1.3
0.4
0.8
0.4
5.2
6.4
4.8
1.4
1.6
2.0
6.9
5.3
3.4
Data Source: Special analyses, USRDS ESRD Database. Point prevalent hemodialysis, peritoneal dialysis, and transplant patients at all ages, with Medicare as primary payer on January 1, 2011, who are continuously enrolled in Medicare Parts A and B from July, 1, 2010 to December 31, 2010, ESRD service date is at least 90 days prior to January 1, 2011, and survived past 2012. Abbreviations: AFIB, atrial fibrillation; AMI, acute myocardial infarction; ASHD, atherosclerotic heart disease; Af Am, African American; Blk, black; CABG, coronary artery bypass grafting; CHF, congestive heart failure; CKD, chronic kidney disease;
CVA/TIA, cerebrovascular accident/transient ischemic attack; CVD, cardiovascular disease; ICD/CRT-D, implantable cardioverter defibrillators/cardiac resynchronization therapy with defibrillator devices; PAD, peripheral arterial disease; PCI, percutaneous coronary interventions; SCA/VA, sudden cardiac arrest and ventricular arrhythmias. a The denominators for all cardiovascular comorbidities are patients described above by modality. b The denominators for PCI and CABG are patients with ASHD by modality. The denominator for ICD/CRT-D is patient with CHF by modality.
Vol 2, ESRD, Ch 9 6
Figure 9.4 Probability of survival of ESRD patients with or without a cardiovascular disease or undergoing a cardiovascular procedure, 2011-2013
(a) ASHD
Data Source: Special analyses, USRDS ESRD Database. Point prevalent hemodialysis, peritoneal dialysis, and transplant patients with Medicare as primary payer on January 1, 2011, who are continuously enrolled in Medicare Parts A and B from July, 1, 2010 to December 31, 2010, and whose first ESRD service date is at least 90 days prior to January 1, 2011, and survived past 2011. Abbreviation: ASHD, atherosclerotic heart disease.
Vol 2, ESRD, Ch 9 7
Figure 9.4 Probability of survival of ESRD patients with or without a cardiovascular disease or undergoing a cardiovascular procedure, 2011-2013
(b) AMI
Data Source: Special analyses, USRDS ESRD Database. Point prevalent hemodialysis, peritoneal dialysis, and transplant patients with Medicare as primary payer on January 1, 2011, who are continuously enrolled in Medicare Parts A and B from July, 1, 2010 to December 31, 2010, and whose first ESRD service date is at least 90 days prior to January 1, 2011, and survived past 2011. Abbreviation: AMI, acute myocardial infarction.
Vol 2, ESRD, Ch 9 8
Figure 9.4 Probability of survival of ESRD patients with or without a cardiovascular disease or undergoing a cardiovascular procedure, 2011-2013
(c) CHF
Data Source: Special analyses, USRDS ESRD Database. Point prevalent hemodialysis, peritoneal dialysis, and transplant patients with Medicare as primary payer on January 1, 2011, who are continuously enrolled in Medicare Parts A and B from July, 1, 2010 to December 31, 2010, and whose first ESRD service date is at least 90 days prior to January 1, 2011, and survived past 2011. Abbreviation: CHF, congestive heart failure.
Vol 2, ESRD, Ch 9 9
Figure 9.4 Probability of survival of ESRD patients with or without a cardiovascular disease or undergoing a cardiovascular procedure, 2011-2013
(d) CVA / TIA
Data Source: Special analyses, USRDS ESRD Database. Point prevalent hemodialysis, peritoneal dialysis, and transplant patients with Medicare as primary payer on January 1, 2011, who are continuously enrolled in Medicare Parts A and B from July, 1, 2010 to December 31, 2010, and whose first ESRD service date is at least 90 days prior to January 1, 2011, and survived past 2011. Abbreviations: CVA/TIA, cerebrovascular accident/transient ischemic attack.
Vol 2, ESRD, Ch 9 10
Figure 9.4 Probability of survival of ESRD patients with or without a cardiovascular disease or undergoing a cardiovascular procedure, 2011-2013
(e) PAD
Data Source: Special analyses, USRDS ESRD Database. Point prevalent hemodialysis, peritoneal dialysis, and transplant patients with Medicare as primary payer on January 1, 2011, who are continuously enrolled in Medicare Parts A and B from July, 1, 2010 to December 31, 2010, and whose first ESRD service date is at least 90 days prior to January 1, 2011, and survived past 2011. Abbreviation: PAD, peripheral arterial disease.
Vol 2, ESRD, Ch 9 11
Figure 9.4 Probability of survival of ESRD patients with or without a cardiovascular disease or undergoing a cardiovascular procedure, 2011-2013
(f) AFIB
Data Source: Special analyses, USRDS ESRD Database. Point prevalent hemodialysis, peritoneal dialysis, and transplant patients with Medicare as primary payer on January 1, 2011, who are continuously enrolled in Medicare Parts A and B from July, 1, 2010 to December 31, 2010, and whose first ESRD service date is at least 90 days prior to January 1, 2011, and survived past 2011. Abbreviation: AFIB, atrial fibrillation.
Vol 2, ESRD, Ch 9 12
Figure 9.4 Probability of survival of ESRD patients with or without a cardiovascular disease or undergoing a cardiovascular procedure, 2011-2013
(g) SCA / VA
Data Source: Special analyses, USRDS ESRD Database. Point prevalent hemodialysis, peritoneal dialysis, and transplant patients with Medicare as primary payer on January 1, 2011, who are continuously enrolled in Medicare Parts A and B from July, 1, 2010 to December 31, 2010, and whose first ESRD service date is at least 90 days prior to January 1, 2011, and survived past 2011. Abbreviations: SCA/VA, sudden cardiac arrest and ventricular arrhythmias.
Vol 2, ESRD, Ch 9 13
Figure 9.4 Probability of survival of ESRD patients with or without a cardiovascular disease or undergoing a cardiovascular procedure, 2011-2013
(h) PCI
Data Source: Special analyses, USRDS ESRD Database. Point prevalent hemodialysis, peritoneal dialysis, and transplant patients with Medicare as primary payer on January 1, 2011, who are continuously enrolled in Medicare Parts A and B from July, 1, 2010 to December 31, 2010, and whose first ESRD service date is at least 90 days prior to January 1, 2011, and survived past 2011. Abbreviation: PCI, percutaneous coronary interventions.
Vol 2, ESRD, Ch 9 14
Figure 9.4 Probability of survival of ESRD patients with or without a cardiovascular disease or undergoing a cardiovascular procedure, 2011-2013
(i) CABG
Data Source: Special analyses, USRDS ESRD Database. Point prevalent hemodialysis, peritoneal dialysis, and transplant patients with Medicare as primary payer on January 1, 2011, who are continuously enrolled in Medicare Parts A and B from July, 1, 2010 to December 31, 2010, and whose first ESRD service date is at least 90 days prior to January 1, 2011, and survived past 2011. Abbreviation: CABG, coronary artery bypass grafting.
Vol 2, ESRD, Ch 9 15
Figure 9.4 Probability of survival of ESRD patients with or without a cardiovascular disease or undergoing a cardiovascular procedure, 2011-2013
(j) ICD / CRT / D
Data Source: Special analyses, USRDS ESRD Database. Point prevalent hemodialysis, peritoneal dialysis, and transplant patients with Medicare as primary payer on January 1, 2011, who are continuously enrolled in Medicare Parts A and B from July, 1, 2010 to December 31, 2010, and whose first ESRD service date is at least 90 days prior to January 1, 2011, and survived past 2011. Abbreviation: ICD/CRT/D, implantable cardioverter defibrillators/cardiac resynchronization therapy with defibrillator devices.
Vol 2, ESRD, Ch 9 16
Table 9.2 Characteristics of patients with heart failure, by treatment modality, 2013
Age
0-21
22-44
45-64
65-74
75+
Sex
Male
Female
Race
White
Black/African
American
Other
Diabetes
No
Yes
Systolic +/- Diastolic heart failure
HD PD
N
8,431
5,714
7,708
5,756
681
4,029
10,116
%
7
887
5,047
4,034
4,170
0.0
6.3
35.7
28.5
29.5
59.6
40.4
54.5
40.7
4.8
28.5
71.5
N
1
100
303
241
164
476
333
555
216
38
%
0.1
12.4
37.5
29.8
20.3
58.8
41.2
68.6
26.7
4.7
323
486
39.9
60.1
Diastolic only heart failure
HD PD
N
1
774
4,413
3,565
3,811
0.0
6.2
35.1
28.4
30.3
5,484
7,080
6,547
5,386
631
3,505
9,059
%
43.6
56.4
52.1
42.9
5.0
27.9
72.1
N
0
63
231
142
125
264
297
344
187
30
203
358
%
0.0
11.2
41.2
25.3
22.3
47.1
52.9
61.3
5.3
36.2
63.8
Heart failure, unspecified
HD PD
N % N %
11
1,852
9,295
6,643
6,858
0.0
7.5
37.7
26.9
27.8
6 0.5
156 13.2
474 40.1
307 26.0
238 20.2
12,573
12,086
12,720
33.3
10,683
1,256
7,095
17,564
51.0
49.0
51.6
43.3
5.1
28.8
71.2
611 51.7
570 48.3
755 63.9
344 29.1
82 6.9
439 37.2
742 62.8
Data Source: Special analyses, USRDS ESRD Database. Point prevalent hemodialysis and peritoneal dialysis patients at all ages, with Medicare as primary payer on January 1, 2011, who are continuously enrolled in Medicare Parts A and B from
July, 1, 2010 to December 31, 2010, ESRD service date is at least 90 days prior to January 1, 2011, and survived past 2012.
Abbreviations: HD, hemodialysis; PD, peritoneal dialysis.
Vol 2, ESRD, Ch 9 17